"Vektor" named the volume of produced vaccine "EpiVacCorona"

“In 2021, in February and March, we jointly produced more than 1.2 million doses of the vaccine, which corresponds to 600 thousand complete kits.

With the help of our industrial partners EpiVac, Vector-BiAlgam and Geropharm, we expect to significantly increase the rate of vaccine production and reach the production volume of 5 million doses per month by summer, "he said in an interview with RIA Novosti.

According to him, at the moment EpiVacCorona is produced at two sites: in the Vector center and in the Vector-BiAlgam company.

Earlier, the head of Vector told about the peculiarities of revaccination with EpiVacCorona.